Alan Fuhrman Insider Trading $LOXO Loxo Oncology, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alan Fuhrman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alan Fuhrman. Alan Fuhrman is Senior Vice President & CFO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Director in Esperion Therapeutics, Inc. ($ESPR) and Chief Financial Officer in Mirna Therapeutics, Inc. ($MIRN) and Director in Loxo Oncology, Inc. ($LOXO) and Director in SpringWorks Therapeutics, Inc. ($SWTX).
Alan Fuhrman in Loxo Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Alan Fuhrman: Director
Holdings: 2,625 shares
Current Value: $104,213
Latest Transaction: Feb 15 2019
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Alan Fuhrman in Loxo Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHV, ESPR, LOXO, SWTX, SYBX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 180.98 | 8,750 | 1,583,575 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 78.58 | 11,000 | 864,380 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 24.18 | 7,812 | 188,894 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 20.91 | 7,812 | 163,349 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 11.35 | 13,000 | 147,550 | 0 | |
| Jun 14 2018 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | A | 180.98 | 8,750 | 1,583,575 | 8,750 | |
| Jun 11 2018 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | M | 11.35 | 2,625 | 29,794 | 13,000 | |
| Jun 11 2018 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Sell | S | 178.07 | 2,625 | 467,437 | 0 | 2.6 K to 0 (-100.00 %) |
| Jun 11 2018 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Buy | M | 11.35 | 2,625 | 29,794 | 2,625 | 0 to 2.6 K |
| Jun 23 2017 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | A | 78.58 | 11,000 | 864,380 | 11,000 | |
| Jun 13 2016 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | A | 24.18 | 7,812 | 188,894 | 7,812 | |
| Jul 30 2015 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | A | 20.91 | 7,812 | 163,349 | 7,812 |
Page: 1